Sanofi Aventis Groupe

Elias Zerhouni, Scientific Advisor to the Chief...





PARIS, February 11 /PRNewswire/ --     Sanofi-aventis is pleased to announce the
collaboration with Dr. Elias
Zerhouni as Scientific Advisor to the Chief Executive Officer, Christopher A.
Viehbacher and to the Senior Vice President, Research and Development, Marc
Cluzel.



    Sanofi-aventis has embarked upon an ambitious program with the goal of
making the company a world leader in healthcare. Sanofi-aventis will be able
to draw upon Dr. Zerhouni's deep experience and knowledge gained over an
impressive career in both academia as well as the Director of the NIH.



    Dr Zerhouni has won numerous awards for research. He has been a member of
the Institute of Medicine of the National Academy of Sciences since 2000 and
received the prestigious Legion d'Honneur from the President of France in
2008.



    Most recently Dr. Zerhouni joined the Bill and Melinda Gates Foundation
as a Senior Fellow.



    Chris Viehbacher said: "Our R&D team and I are excited by the opportunity
to work with such a world reknowned figure as Dr. Zerhouni. In addition to
his outstanding scientific credentials, Dr. Zerhouni's multi cultural
background will help us to address significant public health issues around
the globe."



    Dr. Zerhouni will also chair a Scientific Council for the company,
details of which will be the subject of a future announcement.



About sanofi-aventis

    Sanofi-aventis, a leading global pharmaceutical company, discovers,
develops and distributes therapeutic solutions to improve the lives of
everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York
(NYSE: SNY).